Croissance Ltd (CROISSANCE) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Croissance Ltd on NSE and BSE, with an AI summary of each filing.
Scrutinizers Report and Voting Results
Annual General Meeting · 04 Oct 2026, 11:33 pm
Croissance Limited Approves Loan-to-Equity Conversion and AGM Resolutions Croissance Limited shareholders approved all four resolutions at the 32nd AGM held on 30th Sep'26 with over 99.99% voting approval. Key outcomes include the adoption of FY26 financial statements, the re-appointment of director Hemant Bahri, and the appointment of statutory auditors for a five-year term. Crucially, shareholders passed a special resolution approving the conversion of outstanding loans into equity shares. Total votes polled stood at 1,10,76,621 shares across 12,432 registered shareholders, representing approximately 16.16% of total outstanding equity.
Outcome of Annual General Meeting
Annual General Meeting · 01 Oct 2026, 3:32 am
Annual Report
Others (Uncategorized) · 09 Sept 2026, 2:03 am
Un-audited Financial Results for the Quarter ended 30/06/2026.
Financial Result · 05 Aug 2026, 7:51 pm
Croissance Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakh) ■ Revenue: 3.2 (-88.3% QoQ) ■ EBITDA: -8.4 (+27.2% YoY | Profit to Loss QoQ) ■ EBITDA Margin (%): -260 (Profit to Loss QoQ) ■ PAT: 0.4 (-66.7% YoY | +37.5% QoQ) ■ EPS (INR): 0.00
Resignation of Statutory Auditor.
Change in Auditor · 01 Aug 2026, 12:39 am
Croissance Ltd's Statutory Auditor Resigns Citing Unpaid Fees and Scope Expansion Croissance Limited's statutory auditor, YCRJ & Associates, has resigned effective 31-Jul'26. Key reasons cited include outstanding unpaid audit fees, an inadequate fee structure to support an expanded workload from new financial reporting requirements, and operational difficulties stemming from the company's business expansion and geographical relocation. The resignation was also prompted by the departure of the audit partner responsible for the engagement. The auditor had completed the audit for the period ending 31-Mar'26. The auditor confirmed no other material reasons for resigning.
Croissance Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve Un-audited Financial Results of ....
Intimation · 05 Aug 2026, 5:30 am
Croissance Ltd Board Meeting on 05 Aug'26 to Approve Q1 Results Croissance Limited has scheduled a Board of Directors meeting on 05 Aug'26 to consider and approve its un-audited financial results for the quarter ended 30 Jun'26. In connection with the results, the trading window for designated persons will remain closed from 01 Jul'26 until 48 hours after the results are declared.
Financial Results for the Quarter and Financial Year ended 31/03/2026.
Financial Result · 26 May 2026, 10:59 pm
Croissance Ltd - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lakh) ■ Revenue: 27.7 (+11441.7% QoQ) ■ EBITDA: 2.3 (-94.5% YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 8.4 (Loss to Profit QoQ) ■ PAT: 0.3 (-99.2% YoY | -82.9% QoQ) ■ EPS (INR): 0.00 (-100.0% YoY)
Croissance Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 ,inter alia, to consider and approve Financial Results for the Quarter ....
Intimation · 26 May 2026, 5:30 am
Croissance Limited Sets Board Meeting for Q4 & FY26 Results Croissance Limited has scheduled a Board of Directors meeting for 26th May'26 at 11:00 AM. The primary agenda is to consider and approve the audited financial results for the quarter and financial year ended 31st Mar'26. In connection with the results declaration, the trading window for designated persons has been closed since 01st Apr'26 and will reopen 48 hours after the results are announced. This meeting is a key event for the company's upcoming financial disclosures.
Croissance Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Rescheduling of Board Meeting
Rescheduled / Cancelled · 09 May 2026, 1:46 am
Croissance Limited Reschedules Board Meeting Croissance Limited (Scrip: 531909) announced the rescheduling of its Board of Directors meeting originally set for 08 May'26. The company stated it will inform the exchange of the new meeting date in due course. This intimation follows the previous notice dated 05 May'26, complying with SEBI regulations. The agenda for the meeting was not specified in the notice.
Board Meeting update
Others (Uncategorized) · 07 May 2026, 10:43 pm
Croissance Ltd Board Meeting on 08 May'26 to Approve Q4 & FY26 Results Croissance Limited has scheduled a Board of Directors meeting for 08 May'26 to consider and approve the audited financial results for the quarter and financial year ended 31 Mar'26. The company also confirmed that the trading window for designated persons, which closed on 01 Apr'26, will remain closed until 48 hours after the results are declared. This intimation was filed with the exchange on 07 May'26.
Croissance Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2026 ,inter alia, to consider and approve Audited Financial Results of the Company
Intimation · 08 May 2026, 5:30 am
Croissance Ltd Sets Board Meeting for Q4 and FY26 Results Croissance Limited (BSE: 531909) has scheduled a Board of Directors meeting on 30th May'25 at 5:00 PM. The primary agenda is to consider and approve the audited financial results for the quarter and financial year ending 31st Mar'26. The trading window for designated persons has been closed from 1st Apr'26 and will reopen 48 hours after the results are declared. This date supersedes the previously filed, conflicting date of 8th May'26 for the same purpose.
Results for the Quarter ended 31/12/2025
Financial Result · 07 Jan 2026, 2:28 am
CROISSANCE LIMITED - Financial Result for the Quarter ended 31st Dec'25 (Consolidated, INR Lakhs) ■ Revenue: 0.2 ■ EBITDA: -18.4 (+9.6% YoY | -1.5% QoQ) ■ EBITDA Margin (%): -7646 ■ PAT: 1.9 (Loss to Profit YoY | +21.4% QoQ) ■ EPS (INR): 0.00 (Loss to Profit YoY)
Croissance Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/01/2026 ,inter alia, to consider and approve Un-audited Financial Results
Intimation · 06 Jan 2026, 5:30 am
Croissance Ltd Schedules Board Meeting for Q3 FY26 Results Croissance Ltd (BSE: 531909) announced a Board of Directors meeting scheduled for 06 Jan'26 at 4:00 PM. The primary agenda is to consider and approve the un-audited financial results for the quarter ending 31 Dec'25. In line with this, the trading window for designated persons will remain closed from 01 Jan'26 until 48 hours after the results are declared. This meeting is crucial for assessing the company's Q3 FY26 performance.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hemant Bahri
Acquisition/ Disposal of Shares · 29 Dec 2025, 6:37 pm
Croissance Limited: Promoter Sells 1.42% Stake via Open Market Promoter Hemant Bahri sold 9,70,164 equity shares, representing 1.42% of Croissance Limited's total share capital, via open market transactions between 19-Dec'25 and 24-Dec'25. This disposal reduces his total holding in the company from 24,79,463 shares (3.62% stake) to 15,09,299 shares (2.20% stake). The company's total equity share capital post-transaction remains at 6,85,48,000 shares. This disclosure was made under SEBI's takeover regulations on 26-Dec'25.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hemant Bahri
Acquisition/ Disposal of Shares · 19 Dec 2025, 10:19 pm
Croissance Limited: Promoter Hemant Bahri Sells 0.90% Stake via Open Market Promoter Hemant Bahri of Croissance Limited sold 6,20,902 equity shares, representing 0.90% of total share capital, via open market transactions. The sales occurred on 16-Dec'25 (2,60,230 shares) and 17-Dec'25 (3,60,072 shares). Following the disposal, his shareholding decreased from 31,00,365 shares (4.52%) to 24,79,463 shares (3.62%). The company's total equity share capital before and after the sale remained at 6,85,48,000 shares. This disclosure was made under SEBI's Substantial Acquisition of Shares and Takeover regulations.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hemant Bahri
Acquisition/ Disposal of Shares · 17 Dec 2025, 4:01 pm
Croissance Ltd Promoter Hemant Bahri Sells 0.47% Stake Promoter Hemant Bahri sold 3,25,003 equity shares of Croissance Limited, representing 0.47% of total share capital, via an open market transaction on 10th Dec'25. Post-sale, his shareholding decreased from 34,25,368 shares (4.99%) to 31,00,365 shares (4.52%). The company's total voting capital remains unchanged at 6,85,48,000 shares. This disclosure was made under SEBI's SAST Regulations.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hemant Bahri
Acquisition/ Disposal of Shares · 09 Dec 2025, 3:09 pm
Croissance Limited Promoter Hemant Bahri Sells 0.75% Stake in Open Market Hemant Bahri, a promoter of Croissance Limited, has sold 5,17,038 equity shares through an open market transaction between 3rd Dec'25 and 4th Dec'25. This sale represents 0.75% of the company's total voting capital. Following the disposal, Mr. Bahri's shareholding in the company has decreased from 39,42,406 shares (5.75%) to 34,25,368 shares (4.99%). The disclosure was made to the BSE under SEBI's takeover regulations.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hemant Bahri
Acquisition/ Disposal of Shares · 01 Dec 2025, 6:21 pm
Promoter Hemant Bahri Sells 1.62% Stake in Croissance Limited Hemant Bahri, a promoter of Croissance Limited, has sold a total of 11,07,594 equity shares through open market transactions. The sales occurred on two dates, with 7,594 shares sold on 27 Nov'25 and 11,00,000 shares sold on 28 Nov'25. This disposal of shares, representing 1.62% of the company's total voting capital, has reduced his holding from 50,50,000 shares (7.37%) to 39,42,406 shares (5.75%). The disclosure was made under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hemant Bahri
Acquisition/ Disposal of Shares · 28 Nov 2025, 7:22 pm
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hemant Bahri
Acquisition/ Disposal of Shares · 21 Nov 2025, 4:59 pm
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sangeeta Bahri
Acquisition/ Disposal of Shares · 20 Nov 2025, 8:43 pm
Un-audited Financial Results of the Company for the Quarter and Half-year ended 30.09.2025.
Financial Result · 14 Nov 2025, 1:42 am
Croissance Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve Un-audited Financial Results of ....
Intimation · 13 Nov 2025, 5:30 am
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Others (Uncategorized) · 03 Nov 2025, 8:52 pm
Scrutinizers Report
Annual General Meeting · 02 Oct 2025, 2:22 am